Hormonal GHRH, somatostatin, or ghrelin dysregulation have been suggested as the neuroendocrine changes that underlie decreased plasma GH levels in obesity [15,16]. The gene discussed is GHRH; the disease is obesity due to melanocortin 4 receptor deficiency.